about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene gre...
Read More
25.90
-0.82
(-3.07%)
1.4M
XNAS Volume
XNAS 14 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..